Every material Form 8-K 21Shares Solana Staking ETF has filed with the SEC since July 07, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
The fund's sponsor signed a licensing agreement with FTSE International for the FTSE Solana Index, which will replace the CME CF Solana-Dollar Reference Rate - New York Variant for valuing shares starting August 27, 2026. The filing also shows a fund name change, a restated trust agreement, and a change to quarterly-or-less frequent payment of the sponsor fee, which the filing says are not expected to materially affect holders' rights.
FTSE Solana Index replaces the CME CF benchmark for net asset value starting August 27, 2026, after the CF Benchmarks license terminates August 31, 2026
Licensing agreement dated August 20, 2026 has an expected one-year initial term with automatic one-year renewals
Sponsor fee payment changed from weekly in arrears to at least quarterly in arrears, payable in SOL
Trust renamed from 21Shares Solana ETF to 21Shares Solana Staking ETF on August 25, 2026
21Shares US LLC, sponsor of the 21Shares Solana ETF (TSOL), agreed on July 27, 2026 to voluntarily waive the sponsor fee it receives from the trust for one year, from July 28, 2026 through July 27, 2027. The press release says the fee falls from 0.21% to 0.00% for that period, which lowers the cost of holding the trust for shareholders during the waiver.
Sponsor fee reduced from 0.21% to 0.00%, effective July 28, 2026
Waiver is voluntary and runs through July 27, 2027
Press release announcing the waiver issued July 27, 2026 (Exhibit 99.1)
Press release cites an estimated net staking yield of about 4.29% as of July 20, 2026, which the filing says is not a measure of overall trust performance
The fund's sponsor, 21Shares US LLC, gave notice on June 30, 2026 that it is terminating its licensing agreement with CF Benchmarks, effective August 31, 2026. The benchmark is used to value the Trust's shares daily and calculate its net asset value, so the change affects how the fund is priced. The sponsor plans a replacement license with FTSE International Limited on or about August 24, 2026.
Notice of termination given to CF Benchmarks Ltd. on June 30, 2026, effective August 31, 2026.
Terminated agreement covers the CME CF Solana-Dollar Reference Rate - New York Variant, used to value shares daily and calculate net asset value.
Sponsor intends to license FTSE index data from FTSE International Limited on or about August 24, 2026, with a one-year initial term.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every 21Shares Solana Staking ETF filing is on SEC EDGAR ↗. 8-K briefs of other companies →